Publication Does Not Necessarily Defeat Joint Inventorship
Contributed by Knobbe Martens. Originally published on Patexia; republished here as part of the LexDana archive.
DANA-FARBER CANCER INSTITUTE v. ONO PHARMACEUTICAL CO., LTD.
Before Newman, Lourie, and Stoll. Appeal from the U.S. District Court for the District of Massachusetts
Summary: An individual who contributes “significant building blocks” to an invention may still be an inventor even if the individual publishes the information prior to conception of the claimed subject matter.
Dana-Farber Cancer Institute brought suit against Ono alleging that Dr. Freeman and Dr. Wood should be added as inventors to an Ono patent naming Dr. Honjo as the inventor. Over the years, Freeman, Wood, and Honjo had met and exchanged information relevant to the subject matter of the patent. However, Freeman and Wood did not participate in certain experiments leading to conception. Freeman and Wood had also separately published information relating to their research and filed a provisional patent application that did not list Honjo as an inventor. Nevertheless, the district court concluded that Freeman and Wood should be added as inventors. Ono appealed.
Ono argued the contributions of Freeman and Wood (1) were irrelevant because they published their work prior to conception, and (2) were not a significant contribution to the claims. The Federal Circuit rejected Ono’s first argument because “publication of a portion of a complex invention does not necessarily defeat joint inventorship of that invention.” The Federal Circuit rejected Ono’s second argument because the contributions of Freeman and Wood were “significant building blocks” upon which the patents were built. Thus, the Federal Circuit affirmed.
Editor: Paul Stewart
Written by: Serah Friedman, Ph.D. & Adam Powell
More insights
Federal Circuit Affirms Invalidation of Patent for Lack of Enablement of Claims Directed to a Method of Treating a Patient with a Unit Dosage in Wyeth Llc v Astrazeneca Pharmaceuticals Lp
Written by : Eric Furman, Ph.D. and Ashley C. Morales Key Takeaway: Federal Circuit invalidates patent claims directed to a method for treating non-small cell lung cancer through administration of “a unit dosage” of an irreversible epidermal…
When About Becomes Indefinite Federal Circuit Provides Guidance for Life Science Patent Applications Regarding Limits of Approximation in Enviro Tech v Safe Foods
Written by : Jason J. Jardine and Kenneth O. Aruda, Ph.D. Key Takeaway: The term “about” remains useful in biotech and pharmaceutical claims, but only if the patent provides objective guidance about what the term means. Absent that guidance,…
When Any Patent Means No Patent Federal Circuit Reverses Non Specific Verdict
Written by : Brian C. Barnes and Sophia F. Zahn OLLNOVA TECHNOLOGIES LTD. v. ECOBEE TECHNOLOGIES ULC [OPINION] Before Chen , Cunningham, and Stark. Appeal from the United States District Court for the Eastern District of Texas. Summary : A verdict form…